| ITETX | VIVIX | ITETX / VIVIX | |
| Total Expense Ratio | 1.01 | 0.04 | 2,525% |
| Annual Report Gross Expense Ratio | 1.04 | 0.04 | 2,600% |
| Fund Existence | 23 years | 27 years | - |
| Gain YTD | -1.154 | 11.991 | -10% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 285M | 208B | 0% |
| Annual Yield % from dividends | 1.40 | 2.10 | 67% |
| Returns for 1 year | -5.39 | 6.69 | -81% |
| Returns for 3 years | 6.62 | 33.49 | 20% |
| Returns for 5 years | 21.65 | 66.36 | 33% |
| Returns for 10 years | -5.72 | 134.98 | -4% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VHCIX | 142.27 | 1.63 | +1.16% |
| Vanguard Health Care Index Admiral | |||
| AEDCX | 34.44 | 0.28 | +0.82% |
| Invesco International Value C | |||
| HFYYX | 13.86 | 0.10 | +0.73% |
| Hartford Schroders Intl Multi-Cp Val Y | |||
| BRUNX | 17.38 | 0.04 | +0.23% |
| MFS Blended Research Value Equity R6 | |||
| ARFFX | 18.94 | 0.04 | +0.21% |
| Ariel Focus Investor | |||